ProfileGDS4177 / 218453_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 82% 75% 77% 76% 69% 68% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated235.5482
GSM603099KU-812 non-treated144.9375
GSM603098KCL-22 Imatinib-treated175.3877
GSM603097KCL-22 non-treated157.2576
GSM603102JURL-MK1 Imatinib-treated92.3669
GSM603101JURL-MK1 non-treated81.3468